Fostering and Protecting Your Innovations

Search Our Technologies Search Our Forms

Upcoming Events

  • February 28, 2017 • 8 AM – 5 PM
  • EPNEC, 320 S. Euclid Ave., St. Louis, MO 63110

SAVE THE DATE!  More information to come.



Fimbrion Therapeutics Pioneers Anti-Virulence Solutions to Treat UTIs

By Tom on October 26, 2016

ST. LOUIS – Fimbrion Therapeutics, Inc. is a Washington University startup biopharmaceutical company focused on innovative, antibiotic-sparing drugs for the prevention and treatment of bacterial diseases with an emphasis on urinary tract infection...


Culprit identified as a major cause of vision loss

By Tom on October 4, 2016

The eye’s retina works like film in a camera. The retina’s rods sense dim light, while cone cells detect colors, contrasts and sharp images seen during daylight. A wide range of disorders can damage those rods and cones and lead to vision loss. Bu...


Researchers identify protein critical in causing chronic UTIs

By Tom on September 29, 2016

Researchers have identified a potential way to prevent chronic urinary tract infections (UTIs). Their research points to a key protein that bacteria use to latch onto the bladder and cause UTIs, according to scientists at Washington University Sch...